Skip to main content

mIDH1 inhibitor ivosidenib improves progression-free survival in advanced cholangiocarcinoma

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
mIDH1 inhibitor ivosidenib improves progression-free survival in advanced cholangiocarcinoma

User login

Username

Password

Reset your password

Type	Lead	score